Document is current
Any future updates will be listed below
-
Authors
Takeyama, Masahiro
Sasai, Kana
Miyaguchi, Yasuo
Ogiwara, Kenichi
Furukawa, Shoko
Shimonishi, Naruto
Nakajima, Yuto
Ueda, Hitoshi
Nogami, Keiji https://orcid.org/0000-0002-2415-2194
-
Funding
Funding for this research was provided by:
Takeda Pharmaceutical Company
- License Information
-
More Information
Article History
Received: 9 May 2024
Revised: 5 September 2024
Accepted: 11 September 2024
First Online: 30 October 2024
Declarations
:
: YM and HU are employees of Takeda Pharmaceutical Co., Ltd (Takeda). NS taught a course endowed by CSL Behring. YN has received a grant from Takeda. KN has received research grants from Bayer, Chugai Pharmaceutical, CSL, Fujimoto Pharmaceutical Corp, KM Biologics, Novo Nordisk, Sanofi, Sekisui, Sysmex, and Takeda; and honoraria from Bayer, Chugai Pharmaceutical, CSL, Fujimoto Pharmaceutical Corp, KM Biologics, Novo Nordisk, Sanofi, Sekisui, Sysmex, and Takeda. KO, KS, MT and SF have no competing interests to disclose.
